Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 6, Pages 3253-3269
Publisher
American Society for Clinical Investigation
Online
2020-05-22
DOI
10.1172/jci132876
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting
- (2019) Mark R. Sullivan et al. Cell Metabolism
- Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer
- (2019) Miguel Reina-Campos et al. CANCER CELL
- The AMPK–Parkin axis negatively regulates necroptosis and tumorigenesis by inhibiting the necrosome
- (2019) Seung Baek Lee et al. NATURE CELL BIOLOGY
- Association between Parkinson’s Disease and Risk of Cancer: A PRISMA-compliant Meta-analysis
- (2019) Pengcheng Zhang et al. ACS Chemical Neuroscience
- Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy
- (2018) Adam J. Wolpaw et al. TRENDS IN CELL BIOLOGY
- PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism
- (2018) Changfeng Li et al. DEVELOPMENTAL CELL
- No Parkin Zone: Mitophagy without Parkin
- (2018) Elodie Villa et al. TRENDS IN CELL BIOLOGY
- Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism
- (2018) Michael A. Reid et al. Nature Communications
- PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation
- (2017) Amit Gupta et al. MOLECULAR CELL
- Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression
- (2017) Juan Liu et al. Nature Communications
- PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis
- (2017) Boxi Zhang et al. Cell Reports
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Cullin3–KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression
- (2016) Cen Zhang et al. GENES & DEVELOPMENT
- The importance of serine metabolism in cancer
- (2016) Katherine R. Mattaini et al. JOURNAL OF CELL BIOLOGY
- A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate
- (2016) Michael E Pacold et al. Nature Chemical Biology
- The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis
- (2016) Rong Ye et al. PLoS One
- Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers
- (2016) Edouard Mullarky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer
- (2016) Jinhong Zhu et al. Translational Oncology
- Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma
- (2015) D.-C. Lin et al. CANCER RESEARCH
- Parkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1
- (2015) Seung Baek Lee et al. MOLECULAR CELL
- Cancer’s Fuel Choice: New Flavors for a Picky Eater
- (2015) Gina M. DeNicola et al. MOLECULAR CELL
- NRF2 regulates serine biosynthesis in non–small cell lung cancer
- (2015) Gina M DeNicola et al. NATURE GENETICS
- The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
- (2015) Alicia M. Pickrell et al. NEURON
- The associations between Parkinson’s disease and cancer: the plot thickens
- (2015) Danielle D. Feng et al. Translational Neurodegeneration
- Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
- (2014) Yongxing Gong et al. NATURE GENETICS
- Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies
- (2014) Ferrán Catalá-López et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Serine and glycine metabolism in cancer
- (2014) Ivano Amelio et al. TRENDS IN BIOCHEMICAL SCIENCES
- Parkin and mitochondrial quality control: toward assembling the puzzle
- (2014) Konstanze F. Winklhofer TRENDS IN CELL BIOLOGY
- An emerging role of PARK2 in cancer
- (2013) Liang Xu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders
- (2013) Rafael Tabarés-Seisdedos et al. NATURE REVIEWS NEUROSCIENCE
- Structure of Parkin Reveals Mechanisms for Ubiquitin Ligase Activation
- (2013) J.-F. Trempe et al. SCIENCE
- A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
- (2013) Donald E. Spratt et al. Nature Communications
- Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases
- (2013) B.E. Riley et al. Nature Communications
- Tumour-associated mutant p53 drives the Warburg effect
- (2013) Cen Zhang et al. Nature Communications
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival
- (2012) C. W. S. Yeo et al. CANCER RESEARCH
- PARK2andPACRGare commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcome
- (2012) Marieta I. Toma et al. GENES CHROMOSOMES & CANCER
- Epidemiology and etiology of Parkinson’s disease: a review of the evidence
- (2011) Karin Wirdefeldt et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
- (2011) Richard Possemato et al. NATURE
- Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
- (2011) Jason W Locasale et al. NATURE GENETICS
- PHGDH amplification and altered glucose metabolism in human melanoma
- (2011) Edouard Mullarky et al. Pigment Cell & Melanoma Research
- Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect
- (2011) C. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolomic Analysis and Visualization Engine for LC−MS Data
- (2010) Eugene Melamud et al. ANALYTICAL CHEMISTRY
- Parkinson’s disease and cancer risk: a systematic review and meta-analysis
- (2010) Archna Bajaj et al. CANCER CAUSES & CONTROL
- Parkin Enhances the Expression of Cyclin-dependent Kinase 6 and Negatively Regulates the Proliferation of Breast Cancer Cells
- (2010) Shiam-Peng Tay et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice
- (2010) G. Poulogiannis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation
- (2009) Hui Xiong et al. JOURNAL OF CLINICAL INVESTIGATION
- Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies
- (2009) Selvaraju Veeriah et al. NATURE GENETICS
- Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
- (2008) Derek Narendra et al. JOURNAL OF CELL BIOLOGY
- Parkin as a tumor suppressor gene for hepatocellular carcinoma
- (2008) M Fujiwara et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started